# Bioimpedance Spectroscopy for the Evaluation of Heart Failure

> **NCT02764073** · — · COMPLETED · sponsor: **Grigore T. Popa University of Medicine and Pharmacy** · enrollment: 150 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Bioimpedance spectroscopy
- **DEVICE:** Lung Ultrasonography
- **DEVICE:** Echocardiography

## Key facts

- **NCT ID:** NCT02764073
- **Lead sponsor:** Grigore T. Popa University of Medicine and Pharmacy
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2020-05
- **Final completion:** 2020-05
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2021-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02764073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02764073, "Bioimpedance Spectroscopy for the Evaluation of Heart Failure". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02764073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*